抗苗勒管激素可预测特发性非梗阻性无精子症男性的精子获取成功:多中心横断面研究结果
该多中心横断面研究纳入117例特发性非梗阻性无精子症(iNOA)男性,评估显微切割睾丸精子提取(mTESE)前血清抗苗勒管激素(AMH)对精子获取成功(+SR)的预测价值。结果显示+SR者基线AMH更低(P=0.005)、雌二醇更高(P=0.01);校正混杂因素后较低AMH与+SR相关(OR 0.79,95%CI 0.64-0.93,P=0.03),AMH<4 ng/ml阈值预测+SR的AUC为70.3%(95%CI 59.8-80.7)。
要点
- iNOA患者mTESE前较低的血清AMH与精子获取成功相关(OR 0.79,95%CI 0.64-0.93,P=0.03)。
- AMH<4 ng/ml阈值预测+SR的AUC为70.3%(95%CI 59.8-80.7)。
- 决策曲线分析显示AMH<4 ng/ml阈值具有净临床获益。
核心结论
- iNOA男性中约略多于一半在mTESE时未获取精子,较低术前血清AMH者手术精子获取成功率显著更高。
- AMH<4 ng/ml阈值在预测+SR方面具有满意的敏感性、特异性和阳性预测值。
研究设计与样本
- 多中心横断面研究,纳入三个三级转诊中心连续就诊的117例白种欧洲iNOA男性,均为原发性夫妇不孕且纯男性因素。
- 采用描述性统计比较mTESE未获取精子(-SR)与获取精子(+SR)两组,拟合多变量逻辑回归模型预测+SR并校正可能混杂因素,评估相关因素的诊断准确性,并用决策曲线分析展示临床获益。
主要发现
- 总体60例(51.3%)为-SR,57例(48.7%)为+SR。
- +SR组基线AMH水平更低(P=0.005),雌二醇(E2)水平更高(P=0.01)。
- 多变量逻辑回归分析中,校正年龄、平均睾丸体积、FSH和E2等混杂因素后,较低AMH水平与+SR相关(OR 0.79,95%CI 0.64-0.93,P=0.03)。
- AMH<4 ng/ml阈值预测+SR的准确度最高,AUC为70.3%(95%CI 59.8-80.7)。
- 决策曲线分析显示使用AMH<4 ng/ml阈值具有净临床获益。
关键数值与推荐
- AMH<4 ng/ml为预测mTESE精子获取成功的最佳阈值,AUC 70.3%(95%CI 59.8-80.7)。
- 较低AMH与+SR的OR为0.79(95%CI 0.64-0.93,P=0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要在更大队列、不同中心和不同种族中进行外部验证。
- 关于AMH与iNOA患者精子获取率,尚缺乏系统评价和Meta分析提供高级别证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is it possible to identify a reliable marker of successful sperm retrieval (+SR) in men with idiopathic non-obstructive azoospermia (iNOA) undergoing microdissection testicular sperm extraction (mTESE)? SUMMARY ANSWER: A higher likelihood of +SR during mTESE is observed in men with iNOA and lower preoperative serum anti-Müllerian hormone (AMH) levels, with good predictive accuracy achieved using an AMH threshold of <4 ng/ml. WHAT IS KNOWN ALREADY: AMH has been previously linked to +SR in men with iNOA undergoing mTESE prior to ART. STUDY DESIGN, SIZE, DURATION: A multi-centre cross-sectional study was carried out with a cohort of 117 men with iNOA undergoing mTESE at three tertiary-referral centres. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data from 117 consecutive white-European men with iNOA presenting for primary couple's infertility associated with a pure male factor at three centres were analysed. Descriptive statistics was applied to compare patients with negative (-SR) versus +SR at mTESE. Multivariate logistic regression models were fitted to predict +SR at mTESE, after adjusting for possible confounders. Diagnostic accuracy of the factors associated with +SR was assessed. Decision curve analyses were used to display the clinical benefit. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 60 (51.3%) men had an -SR and 57 (48.7%) had a +SR at mTESE. Patients with +SR had lower levels of baseline AMH (P = 0.005) and higher levels of estradiol (E2) (P = 0.01). At multivariate logistic regression analysis, lower levels of AMH (odds ratio: 0.79; 95% CI: 0.64-0.93, P = 0.03) were associated with +SR at mTESE, after adjusting for possible confounders (e.g. age, mean testicular volume, FSH, and E2). A threshold of AMH <4 ng/ml achieved the highest accuracy for +SR at mTESE, with an AUC of 70.3% (95% CI: 59.8-80.7). Decision curve analysis displayed the net clinical benefit of using an AMH <4 ng/ml threshold. LIMITATIONS, REASONS FOR CAUTION: There is a need for external validation in even larger cohorts, across different centres and ethnicities. Systematic reviews and meta-analysis to provide high level of evidence are lacking in the context of AMH and SR rates in men with iNOA. WIDER IMPLICATIONS OF THE FINDINGS: Current findings suggest that slightly more than one in two men with iNOA had -SR at mTESE. Overall, men with iNOA with lower levels of AMH had a significantly higher percentage of successful SR at surgery. A threshold of <4 ng/ml for circulating AMH ensured satisfactory sensitivity, specificity, and positive predictive values in the context of +SR at mTESE. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by voluntary donations from the Urological Research Institute (URI). All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Pozzi E, Raffo M, Negri F, et al. Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study. Hum Reprod. 2023. PMID: 37322566. doi:10.1093/humrep/dead125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。